Science Explorer Back to mapMap
Discussion
Company · Nîmes · France

Advicenne Pharma (France)

advicenne.com/enROR OpenAlex
Research works
12
▼ 70% vs 2018-21
Citations
125
10.5 per fractional work
Top-10% rate
3.4%
all institutions 10.0%
Open access
61%
world 40%
International
53%
world 18%
Advicenne Pharma (France)

Not ranked overall: Advicenne Pharma (France) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Advicenne Pharma (France) work in?

In all years, 71% of research at Advicenne Pharma (France) is in Health Sciences, 17% in Life Sciences. Its largest fields are Medicine (67%), Biochemistry, Genetics and Molecular Biology (12%), Business, Management and Accounting (8%). It does 2.0× the world's share of Health Sciences.

Health Sciences: 8 fractional works · 70.6% of its workMedicine: 8 fractional works · 67.4% of its workNephrology: 1 fractional works · 12.2% of its workPulmonary and Respiratory Medicine: 1 fractional works · 8.9% of its workAnesthesiology and Pain Medicine: 1 fractional works · 7.9% of its workGastroenterology: 1 fractional works · 6.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 5.2% of its workEpidemiology: 0 fractional works · 4.0% of its workPsychiatry and Mental health: 0 fractional works · 3.5% of its workPharmacology: 0 fractional works · 2.8% of its workHepatology: 0 fractional works · 2.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 2.4% of its workPathology and Forensic Medicine: 0 fractional works · 2.1% of its workSurgery: 0 fractional works · 2.1% of its workFamily Practice: 0 fractional works · 1.5% of its workRheumatology: 0 fractional works · 1.4% of its workUrology: 0 fractional works · 1.4% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.9% of its workNeurology: 0 fractional works · 0.9% of its workOncology: 0 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workGeriatrics and Gerontology: 0 fractional works · 0.3% of its workObstetrics and Gynecology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 3.2% of its workGeneral Health Professions: 0 fractional works · 2.8% of its workEmergency Medical Services: 0 fractional works · 0.4% of its workLife Sciences: 2 fractional works · 17.5% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 11.8% of its workMolecular Biology: 1 fractional works · 8.4% of its workGenetics: 0 fractional works · 1.4% of its workClinical Biochemistry: 0 fractional works · 1.3% of its workBiochemistry: 0 fractional works · 0.7% of its workNeuroscience: 1 fractional works · 4.7% of its workDevelopmental Neuroscience: 1 fractional works · 4.7% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.9% of its workPharmacology: 0 fractional works · 0.9% of its workSocial Sciences: 1 fractional works · 10.9% of its workBusiness, Management and Accounting: 1 fractional works · 8.4% of its workAccounting: 1 fractional works · 8.4% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.5% of its workEconomics and Econometrics: 0 fractional works · 1.5% of its workSocial Sciences: 0 fractional works · 0.9% of its workLaw: 0 fractional works · 0.9% of its workPhysical Sciences: 0 fractional works · 1.0% of its workChemistry: 0 fractional works · 0.9% of its workAnalytical Chemistry: 0 fractional works · 0.9% of its workEngineering: 0 fractional works · 0.1% of its workALL ITS WORKAdvicenne Pharma(France)12fractional works, all years
Life Sciences17%Physical Sciences1%Health Sciences71%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 10 fields, with their numbers
    1. Medicine867.4%
    2. Health Professions03.2%
    1. Biochemistry, Genetics and Molecular Biology111.8%
    2. Neuroscience14.7%
    3. Pharmacology, Toxicology and Pharmaceutics00.9%
    1. Business, Management and Accounting18.4%
    2. Economics, Econometrics and Finance01.5%
    3. Social Sciences00.9%
    1. Chemistry00.9%
    2. Engineering00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Advicenne Pharma (France)?

Ranked on the quality score, Maria A. Manso-Silván, Catherine Guittet and Luc‐André Granier lead among researchers whose main affiliation is Advicenne Pharma (France).

  1. 1 Maria A. Manso-Silván France · #2,238,158 worldwide 1.3k citations · 41 works
  2. 2 Catherine Guittet France · #3,569,495 worldwide 192 citations · 19 works
  3. 3 Luc‐André Granier France · #3,877,841 worldwide 351 citations · 26 works
All ranked researchers at Advicenne Pharma (France)

What are the most cited papers from Advicenne Pharma (France)?

The most cited paper from Advicenne Pharma (France) is "Efficacy of oral midazolam for minimal and moderate sedation in pediatric patients: A systematic review" (Maria A. Manso-Silván, Catherine Guittet, François Vandenhende et al., 2019), with 73 citations. Next come "Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin" (24) and "Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments" (23).

Most cited papers
#PaperReleasedCitations
1 Efficacy of oral midazolam for minimal and moderate sedation in pediatric patients: A systematic review Maria A. Manso-Silván, Catherine Guittet, François Vandenhende et al. · Pediatric Anesthesia ReviewOpen access 20 Sep 2019 73
2 Population pharmacokinetic evaluation of ADV6209, an innovative oral solution of midazolam containing cyclodextrin Frédéric Marçon, Catherine Guittet, Maria A. Manso-Silván et al. · European Journal of Pharmaceutical Sciences Open access 6 Dec 2017 24
3 Efficacy and safety of an innovative prolonged-release combination drug in patients with distal renal tubular acidosis: an open-label comparative trial versus standard of care treatments Aurélia Bertholet-Thomas, Catherine Guittet, Maria A. Manso-Silván et al. · Pediatric Nephrology Open access 26 Jul 2020 23
4 Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis Aurélia Bertholet‐Thomas, Catherine Guittet, Maria A. Manso-Silván et al. · Pediatric Nephrology Open access 26 Feb 2021 17
5 A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209) Catherine Guittet, Maria A. Manso-Silván, Ingrid Burton et al. · Pharmaceutical Research 2 Jun 2017 15
All 25 most cited papers, with filters and sorting

Which research topics does Advicenne Pharma (France) publish most on?

By volume in 2022-now: Ion Transport and Channel Regulation, Renal function and acid-base balance, Metabolism and Genetic Disorders and Mobile Health and mHealth Applications.

Ion Transport and Channel Regulation: 0 fractional worksRenal function and acid-base balance: 0 fractional worksMetabolism and Genetic Disorders: 0 fractional worksMobile Health and mHealt…0Mobile Health and mHealth Applications: 0 fractional worksIntellectual Property Law: 0 fractional worksGastroesophageal reflux and treatments: 0 fractional worksElectrolyte and hormonal disorders: 0 fractional worksDialysis and Renal Disease Management: 0 fractional worksMedication Adherence and Compliance: 0 fractional worksChronic Kidney Disease and Diabetes: 0 fractional works
Molecular BiologyNephrologyClinical BiochemistryGeneral Health Professions4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Ion Transport and Channel Regulation Molecular Biology 0 works
  2. 2 Renal function and acid-base balance Nephrology 0 works
  3. 3 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
  4. 4 Mobile Health and mHealth Applications General Health Professions 0 works
  5. 5 Intellectual Property Law Law 0 works
  6. 6 Gastroesophageal reflux and treatments Gastroenterology 0 works
  7. 7 Electrolyte and hormonal disorders Pulmonary and Respiratory Medicine 0 works
  8. 8 Dialysis and Renal Disease Management Nephrology 0 works
  9. 9 Medication Adherence and Compliance Family Practice 0 works
  10. 10 Chronic Kidney Disease and Diabetes Nephrology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.0%not open39.0%

World: 40% of research is openly available.

with international co-authors52.9%domestic only47.1%

World: 18% is written across borders.

How has Advicenne Pharma (France)'s research output changed?

Output in 2022-2025 was 70% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Advicenne Pharma (France) as a percentage of every work published that year, 0.0000045% in 2024.

still counting0.000020%0.000040%0.000060%Advicenne Pharma (France)0.0000075% in 202520102020

Fractional works of Advicenne Pharma (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Nîmes

All research institutions in Nîmes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Advicenne Pharma (France). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.